Filing Details

Accession Number:
0001209191-16-095843
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-04 18:52:59
Reporting Period:
2016-02-02
Filing Date:
2016-02-04
Accepted Time:
2016-02-04 18:52:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Policy, Access & Value No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-02 17,299 $0.01 96,262 No 4 A Direct
Common Stock Disposition 2016-02-03 4,300 $89.91 91,962 No 4 S Direct
Common Stock Disposition 2016-02-03 3,700 $91.01 88,262 No 4 S Direct
Common Stock Disposition 2016-02-03 900 $91.82 87,362 No 4 S Direct
Common Stock Disposition 2016-02-03 1,266 $92.79 86,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2016-02-02 34,482 $0.00 34,482 $91.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,482 2026-02-01 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Footnotes
  1. Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019.
  2. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  3. Open market sales reported on this line occurred at a weighted average price of $89.91 (range $89.31 to $90.27).
  4. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  5. Open market sales reported on this line occurred at a weighted average price of $91.01 (range $90.37 to $91.35).
  6. Open market sales reported on this line occurred at a weighted average price of $91.82 (range $91.37 to $92.26).
  7. Open market sales reported on this line occurred at a weighted average price of $92.79 (range $92.42 to $93.11).
  8. The option vests in 16 quarterly installments from 02/02/2016.